P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A)

Kowanetz, M., Vu, M., Wu, J., Koeppen, H., Kohrt, H., Gettinger, S., … Hegde, P. (2014). P13. Intra-tumoral and surrogate immune responses in patients treated with the engineered anti-PD-L1 antibody (MPDL3280A). Journal for ImmunoTherapy of Cancer, 2(S2). https://doi.org/10.1186/2051-1426-2-s2-p4